Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_assertion type Assertion NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_head.
- NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_assertion description "[At high glucose concentrations, the activity and mRNA expression of CuZnSOD increased similarly in all groups (diabetic subjects with angiopathy: 0.93 +/- 0.26 units/mg protein, 9.4 +/- 2.1 mRNA); that of CAT and GPX increased in only control subjects and diabetic subjects without angiopathy (diabetic subjects with angiopathy: 0.33 +/- 0.09 units/mg protein and 5.0 +/- 1.4 mRNA; 0.54 +/- 0.10 units/mg protein and 2.3 +/- 1.0 mRNA, respectively).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_provenance.
- NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_assertion evidence source_evidence_literature NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_provenance.
- NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_assertion SIO_000772 15983321 NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_provenance.
- NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_assertion wasDerivedFrom befree-20140225 NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_provenance.
- NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_assertion wasGeneratedBy ECO_0000203 NP550114.RA8Kz3KzdWwrur46QDUaO1cMZniJqs_5Jl48xX_4FvPc8130_provenance.